To treat HER2-positive GBM, Nabil Ahmed et al. developed HER2-specific CAR-modified virus-specific T cells (CAR VS Ts-HER2) with an FRP5-based exodomain and a CD28.ζ endodomain [50]. The gene discussed is ERBB2; the disease is glioblastoma.